Selegiline for Parkinson’s Disease (Eldepryl)

Selegiline, commonly known by the brand name Eldepryl, is a selective monoamine oxidase type B (MAO-B) inhibitor used in the management of Parkinson’s disease (PD). It enhances dopaminergic function in the brain by preventing the breakdown of dopamine, helping to alleviate motor symptoms either as monotherapy in early PD or as an adjunct to levodopa in advanced stages.

About selegiline

Selegiline works by selectively and irreversibly inhibiting MAO-B, an enzyme responsible for dopamine metabolism in the brain. This action potentiates endogenous dopamine levels and prolongs the effects of exogenous levodopa, providing symptomatic relief in PD patients. Originally investigated as a potential neuroprotective agent due to preclinical evidence of dopaminergic neuron protection, clinical trials like DATATOP demonstrated its ability to delay the need for levodopa therapy and reduce disability progression in early PD.

In more advanced PD, selegiline reduces end-of-dose motor fluctuations and allows for lower levodopa doses, improving overall motor function as measured by Unified Parkinson’s Disease Rating Scale (UPDRS) scores. Available in oral tablets, capsules, and orally disintegrating tablets (ODT), it achieves selective MAO-B inhibition at low plasma levels, minimizing non-selective MAO-A effects that could lead to dietary restrictions.

Key facts about selegiline

• Selegiline is a

  selective MAO-B inhibitor

  primarily used for Parkinson’s disease.
• Typical dose:

  10 mg daily

  (5 mg twice daily for oral forms; lower for ODT).
• Common brand:

  Eldepryl

  .
• Used in

  early PD

  as monotherapy or

  advanced PD

  with levodopa.
• May delay levodopa initiation by symptomatic benefits, though neuroprotective claims remain debated.

When to take selegiline

Selegiline should be taken exactly as prescribed, typically in the morning and midday to avoid insomnia from its mild stimulant effects. Oral disintegrating tablets (like Zelapar) are placed on the tongue without water, dissolving quickly for better bioavailability. Avoid taking it in the evening. If switching from oral selegiline to ODT, a washout period may be needed to prevent excessive MAO-B inhibition.

For patients on levodopa, selegiline is added to smooth motor fluctuations, often reducing ‘OFF’ time by about 2 hours daily. Consistent timing with meals can help manage gastrointestinal side effects.

How to take selegiline

Follow your doctor’s instructions precisely. Standard dosing for oral selegiline is 5 mg twice daily with breakfast and lunch. Orally disintegrating forms start at 1.25 mg daily, increasing to 2.5 mg after 6 weeks. Do not crush or chew regular tablets; swallow whole.

• Use a

  medicine measure

  for liquid forms if prescribed.
• If you miss a dose, take it as soon as remembered unless near the next dose—do not double up.
• For ODT: Peel open pouch, place tablet on tongue, allow to dissolve (do not swallow whole).

Regular monitoring of symptoms via UPDRS can guide adjustments, as efficacy improves over time (e.g., significant UPDRS reductions at 3–60 months).

Common questions about selegiline

How long does selegiline take to work?

Benefits may appear within weeks, with peak effects on UPDRS scores increasing over 1–60 months of use. In early PD, it delays levodopa need by months to years.

How long do you take selegiline for?

Indefinitely for ongoing PD management, as monotherapy or adjunct. Long-term studies up to 5 years show sustained benefits without tolerance.

Can you take selegiline on an empty stomach?

Yes, but taking with food may reduce nausea. Avoid tyramine-rich foods at higher doses to prevent hypertensive crisis, though selective MAO-B inhibition at 10 mg/day minimizes this risk.

Can you take selegiline at night?

No—morning/midday dosing prevents sleep interference from increased dopamine activity.

Who can and cannot take selegiline?

Most adults with PD can take it, but avoid if you have pheochromocytoma, thyrotoxicosis, or are on certain antidepressants (e.g., SSRIs, risking serotonin syndrome). Use caution in dementia or fall-prone patients due to potential mortality signals, though meta-analyses refute broad risks.

Pregnancy and breastfeeding

Selegiline is not routinely recommended during pregnancy or breastfeeding due to limited data. Consult a specialist—weigh risks of PD progression against fetal exposure. Animal studies show no teratogenicity, but human trials are lacking.

Selegiline with food, alcohol, and other medicines

At therapeutic doses (≤10 mg/day), no strict tyramine restrictions apply due to MAO-B selectivity. However, high tyramine foods (aged cheese, cured meats) may pose risks at higher doses. Limit alcohol, as it may exacerbate side effects like dizziness.

Key interactions:

Inform your doctor of all medications, including over-the-counter and herbal supplements like St. John’s wort.

Dosage

The usual adult dose is 10 mg daily, split as 5 mg morning and lunch. ODT: max 2.5 mg/day. Reduce in hepatic/renal impairment. Pediatrics: Not approved. Elderly: Start low, titrate slowly.

Meta-analyses confirm dose-dependent UPDRS improvements without increased neuropsychiatric events long-term.

If you take too much selegiline

Overdose symptoms: agitation, hallucinations, hypertension, seizures. Seek emergency help immediately. Treatment is supportive; no specific antidote.

Stopping selegiline

Do not stop abruptly—withdrawal may worsen PD symptoms. Taper under medical supervision. Discontinuation syndrome is rare but monitor for fluctuations.

Side effects

Selegiline is generally well-tolerated. Common side effects (>1/100):

• Nausea, dry mouth, dizziness.
• Insomnia, headache.
• Postural hypotension.

Serious (report urgently): hallucinations, severe hypertension, serotonin syndrome (fever, rigidity). Long-term: Higher adverse event risk vs. placebo, mainly neuropsychiatric, but not statistically significant vs. controls. No confirmed mortality increase per meta-analyses.

How to cope with selegiline side effects

• Nausea: Take with food; ginger tea.
• Dizziness: Rise slowly; stay hydrated.
• Insomnia: Avoid afternoon dose if needed.
• Dry mouth: Sugar-free gum, frequent sips of water.
• Consult doctor if persistent—dose adjustment or switch to rasagiline possible.

Frequently Asked Questions (FAQs)

Q: Is selegiline neuroprotective?

Preclinical data suggested yes, but clinical evidence shows symptomatic benefits primarily; disease modification unproven.

Q: Does selegiline reduce ‘OFF’ time?

Yes, by ~2.2 hours/day vs. 0.6 for placebo in trials.

Q: Can selegiline replace levodopa?

No, but delays its need in early PD.

Q: What if I forget a dose?

Take ASAP unless near next dose; never double.

Q: Is selegiline safe long-term?

Yes, up to 5+ years; monitor for adverse events.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete